LONDON: A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that led to a pause in testing, a spokesman for the pharmaceutical company AstraZeneca said on Thursday. The study participant in the late-stage trials reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, …
Read More »Vaccine trial stopped after neurological symptoms were detected
